Simon Jeremy Fry - 18 Dec 2024 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)

Role
Director
Signature
/s/ Simon Jeremy Fry
Issuer symbol
CDT
Transactions as of
18 Dec 2024
Net transactions value
+$29,820
Form type
4
Filing time
20 Dec 2024, 17:06:29 UTC
Next filing
01 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDT Stock Option (Right to Buy) Award $29,820 +420,000 $0.0710 420,000 18 Dec 2024 Common Stock 420,000 $0.0710 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan, which were granted at the conclusion of the Issuer's 2024 annual meeting of stockholders.
F2 The options will vest in equal annual installments on the first three anniversaries of the grant date.